ANTI-TUMOR 1-(X-ARYL)-3,3-DIALKYLTRIAZENES .1. QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS VS L1210 LEUKEMIA IN MICE

被引：93

作者：

HATHEWAY, GJ

HANSCH, C

KIM, KH

MILSTEIN, SR

SCHMIDT, CL

SMITH, RN

QUINN, FR

机构：

[1] POMONA COLL,DEPT CHEM,CLAREMONT,CA 91711

[2] NCI,DIV CANC TREATMENT,MED CHEM LAB,DRUG DESIGN & CHEM SECT,BETHESDA,MD 20014

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1978年 / 21卷 / 06期

关键词：

D O I：

10.1021/jm00204a012

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：563 / 574

页数：12

共 34 条

[1]

BEAL DD, 1975, J NATL CANCER I, V54, P951

[2]

BENJAMIN RS, 1976, NEOPLASMS SKIN MALIG

[3]

CLARKE DA, 1955, P SOC EXP BIOL MED, V90, P484

[4]

COHEN SM, 1972, CANCER-AM CANCER SOC, V29, P1489, DOI 10.1002/1097-0142(197206)29:6<1489::AID-CNCR2820290612>3.0.CO

[5]

2-4

[6]

COMIS RL, 1976, CANCER TREAT REP, V60, P165

[7] TUMOR INHIBITORY TRIAZENES - STRUCTURAL REQUIREMENTS FOR AN ACTIVE METABOLITE [J].

CONNORS, TA ;

GODDARD, PM ;

MERAI, K ;

ROSS, WCJ ;

WILMAN, DEV .

BIOCHEMICAL PHARMACOLOGY, 1976, 25 (03) :241-246

[8] SPECIFIC CARCINOGENIC AND TERATOGENIC EFFECTS OF INDIRECT ALKYLATING METHYL AND ETHYL COMPOUNDS, AND THEIR DEPENDENCY ON STAGES OF ONTOGENIC DEVELOPMENTS [J].

DRUCKREY, H .

XENOBIOTICA, 1973, 3 (05) :271-303

[9] USE OF CLUSTER-ANALYSIS IN DEVELOPMENT OF STRUCTURE-ACTIVITY RELATIONS FOR ANTITUMOR TRIAZENES [J].

DUNN, WJ ;

GREENBERG, MJ ;

CALLEJAS, SS .

JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) :1299-1301

[10] CRYSTAL-STRUCTURE OF ANTITUMOR AGENT 5-(3,3-DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE MONOHYDRATE HYDROCHLORIDE (NSC-45388) [J].

EDWARDS, SL ;

SHERFINSKI, JS ;

MARSH, RE .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1974, 96 (08) :2593-2597

← 1 2 3 4 →